These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Drugs in phase I and phase II clinical trials for systemic sclerosis. Chung MP; Chung L Expert Opin Investig Drugs; 2020 Apr; 29(4):349-362. PubMed ID: 32178544 [No Abstract] [Full Text] [Related]
23. [Do specific antifibrotic properties of immunosuppressive drugs used in the treatment of systemic sclerosis exist?]. Verrecchia F; Michel L; Keshtmand H; Wang Y; Launay D; Farge D Rev Med Interne; 2009 Nov; 30(11):955-62. PubMed ID: 19349102 [TBL] [Abstract][Full Text] [Related]
24. Hematopoietic stem cell transplantation for systemic sclerosis: history and current status. Burt RK; Milanetti F Curr Opin Rheumatol; 2011 Nov; 23(6):519-29. PubMed ID: 21857226 [TBL] [Abstract][Full Text] [Related]
25. Cellular Therapies in Systemic Sclerosis: Recent Progress. van Rhijn-Brouwer FC; Gremmels H; Fledderus JO; Radstake TR; Verhaar MC; van Laar JM Curr Rheumatol Rep; 2016 Feb; 18(2):12. PubMed ID: 26943351 [TBL] [Abstract][Full Text] [Related]
27. An update on the pharmacotherapeutic options and treatment strategies for systemic sclerosis. McMahan ZH; Volkmann ER Expert Opin Pharmacother; 2020 Nov; 21(16):2041-2056. PubMed ID: 32674612 [TBL] [Abstract][Full Text] [Related]
28. An update on recent randomized clinical trials in systemic sclerosis. Boleto G; Avouac J; Allanore Y Joint Bone Spine; 2021 Oct; 88(5):105184. PubMed ID: 33887472 [TBL] [Abstract][Full Text] [Related]
31. Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: A Systematic Review and Meta-Analysis. Shouval R; Furie N; Raanani P; Nagler A; Gafter-Gvili A Biol Blood Marrow Transplant; 2018 May; 24(5):937-944. PubMed ID: 29374527 [TBL] [Abstract][Full Text] [Related]
32. Management of interstitial lung disease in systemic sclerosis: lessons from SLS and FAST. Fathi N; Furst DE; Clements PJ Curr Rheumatol Rep; 2007 May; 9(2):144-50. PubMed ID: 17502045 [TBL] [Abstract][Full Text] [Related]
33. [Long-term treatments for systemic sclerosis: what are the perspectives?]. Mouthon L; Agard C; Garcia De La Peña-Lefebvre P; Guillevin L Ann Med Interne (Paris); 2002 Jun; 153(4):265-75. PubMed ID: 12218893 [TBL] [Abstract][Full Text] [Related]
37. Immunosuppressive Therapy After Autologous Hematopoietic Stem Cell Transplantation in Systemic Sclerosis Patients-High Efficacy of Rituximab. Gernert M; Tony HP; Fröhlich M; Schwaneck EC; Schmalzing M Front Immunol; 2021; 12():817893. PubMed ID: 35111167 [TBL] [Abstract][Full Text] [Related]
38. Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group. Jordan S; Distler JH; Maurer B; Huscher D; van Laar JM; Allanore Y; Distler O; Ann Rheum Dis; 2015 Jun; 74(6):1188-94. PubMed ID: 24442885 [TBL] [Abstract][Full Text] [Related]
39. Pharmacological treatments for SSc-ILD: Systematic review and critical appraisal of the evidence. Vonk MC; Smith V; Sfikakis PP; Cutolo M; Del Galdo F; Seibold JR Autoimmun Rev; 2021 Dec; 20(12):102978. PubMed ID: 34718159 [TBL] [Abstract][Full Text] [Related]
40. High frequency of corticosteroid and immunosuppressive therapy in patients with systemic sclerosis despite limited evidence for efficacy. Hunzelmann N; Moinzadeh P; Genth E; Krieg T; Lehmacher W; Melchers I; Meurer M; Müller-Ladner U; Olski TM; Pfeiffer C; Riemekasten G; Schulze-Lohoff E; Sunderkoetter C; Weber M; Arthritis Res Ther; 2009; 11(2):R30. PubMed ID: 19261182 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]